You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epothilones

Showing 26 - 50 of 75
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoid, Neuroendocrine Tumors Trial in United States (EPO906 epothilone B)

Completed
  • Carcinoid
  • Neuroendocrine Tumors
  • EPO906 epothilone B
  • Chicago, Illinois
  • +4 more
Feb 28, 2017

Prostatic Tumors Trial in United States (epothilone b)

Completed
  • Prostatic Neoplasms
  • epothilone b
  • Long Beach, California
  • +4 more
Feb 7, 2017

Breast Tumors Trial in Lebanon, New Brunswick (epothilone b)

Completed
  • Breast Neoplasms
  • epothilone b
  • Lebanon, New Hampshire
  • +1 more
Feb 7, 2017

Cancer Trial in Washington, Detroit (Ixabepilone)

Completed
  • Cancer
  • Washington, District of Columbia
  • +1 more
Jan 27, 2017

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in San Francisco (ixabepilone,

Completed
  • Adenocarcinoma of the Prostate
  • +2 more
  • San Francisco, California
    UCSF Helen Diller Family Comprehensive Cancer Center
Feb 21, 2017

Adult Anaplastic Astrocytoma, Adult Giant Cell Glioblastoma, Adult Gliosarcoma Trial in United States (ixabepilone,

Completed
Has Results
  • Adult Anaplastic Astrocytoma
  • +3 more
  • Atlanta, Georgia
  • +4 more
Sep 15, 2017

Breast Cancer Trial in Barcelona, Madrid, Valencia (Epothilone D, Herceptin)

Completed
  • Breast Cancer
  • Barcelona, Spain
  • +5 more
Nov 1, 2016

Carcinoma, Non-small-cell Lung Trial in United States (Epothilone)

Completed
  • Carcinoma, Non-small-cell Lung
  • Birmingham, Alabama
  • +15 more
Feb 9, 2016

Breast Tumor Trial in Canada, United States (Sagopilone (ZK 219477))

Completed
  • Breast Neoplasm
  • Sagopilone (ZK 219477)
  • Birmingham, Alabama
  • +24 more
Nov 11, 2015

Solid Tumor Trial in Miami (Ixabepilone, Sunitinib)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Miami, Florida
    University of Miami Sylvester Comprehensive Cancer Center
Oct 8, 2015

NSCLC (NSCLC) Trial in Chuo-Ku (Ixabepilone, 32 mg/m^2 + Carboplatin, 5 mg/min/mL, Ixabepilone, 32 mg/m^2 + Carboplatin, 6

Completed
Has Results
  • Non-small Cell Lung Cancer (NSCLC)
  • Ixabepilone, 32 mg/m^2 + Carboplatin, 5 mg/min/mL
  • Ixabepilone, 32 mg/m^2 + Carboplatin, 6 mg/min/mL
  • Chuo-Ku, Tokyo, Japan
    Local Institution
Feb 9, 2016

Metastatic Breast Cancer Trial in Worldwide (ixabepilone, docetaxel, trastuzumab)

Completed
Has Results
  • Metastatic Breast Cancer
  • Caen, France
  • +18 more
Feb 9, 2016

Fallopian Tube Cancer, Female Reproductive Cancer, Recurrent Breast Cancer Trial in United States (ixabepilone, pegylated

Completed
Has Results
  • Fallopian Tube Cancer
  • +6 more
  • Farmington, Connecticut
  • +4 more
Feb 11, 2016

Metastatic Breast Cancer Trial in United States (Ixabepilone)

Completed
Has Results
  • Metastatic Breast Cancer
  • Birmingham, Alabama
  • +56 more
Feb 9, 2016

Triple Negative Locally Advanced Non-resectable Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (ixabepilone,

Completed
Has Results
  • Triple Negative Locally Advanced Non-resectable Breast Cancer
  • Metastatic Breast Cancer
  • Graz, Austria
  • +18 more
Feb 9, 2016

Locally Advanced or Metastatic Breast Cancer Trial in New Brunswick, Brisbane, Modena (Ixabepilone, 32 mg/m^2 + Lapatinib, 1000

Terminated
Has Results
  • Locally Advanced or Metastatic Breast Cancer
  • Ixabepilone, 32 mg/m^2 + Lapatinib, 1000 mg
  • +3 more
  • New Brunswick, New Jersey
  • +2 more
Feb 9, 2016

Metastatic Breast Cancer Trial in Toulouse Cedex 3, Milano (Ixabepilone, Epirubicin)

Completed
Has Results
  • Metastatic Breast Cancer
  • Toulouse Cedex 3, France
  • +1 more
Feb 9, 2016

Metastatic Breast Cancer Trial in Worldwide (Ixabepilone, 16 mg/m^2 + Bevacizumab, 10 mg/kg, Ixabepilone, 40 mg/m^2 +

Completed
Has Results
  • Metastatic Breast Cancer
  • Ixabepilone, 16 mg/m^2 + Bevacizumab, 10 mg/kg
  • +2 more
  • Burbank, California
  • +24 more
Feb 9, 2016

Breast Tumors Trial in United States (Ixabepilone, 40 mg/m^2 + Capecitabine, 1000 mg/m^2, Ixabepilone, 32 mg/m^2 + Capecitabine,

Terminated
Has Results
  • Breast Neoplasms
  • Ixabepilone, 40 mg/m^2 + Capecitabine, 1000 mg/m^2
  • +2 more
  • Tuscaloosa, Alabama
  • +59 more
Feb 9, 2016

Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma Trial in Rochester

Terminated
  • Recurrent Adult Soft Tissue Sarcoma
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Apr 14, 2015

Cancer Trial in Washington, Detroit (Ixabepilone, 5 mg/d, Ixabepilone, 10 mg/d, Ixabepilone, 15 mg/d)

Completed
Has Results
  • Cancer
  • Ixabepilone, 5 mg/d
  • +7 more
  • Washington, District of Columbia
  • +1 more
Feb 9, 2016

Carcinoma, Non Small Cell Lung Trial in Germany (Sagopilone (BAY86-5302, ZK 219477))

Completed
  • Carcinoma, Non Small Cell Lung
  • Sagopilone (BAY86-5302, ZK 219477)
  • Löwenstein, Baden-Württemberg, Germany
  • +16 more
Dec 2, 2014

Breast Cancer Trial in Worldwide (Ixabepilone, Paclitaxel, Cyclophosphamide)

Completed
Has Results
  • Breast Cancer
  • Palm Springs, California
  • +49 more
Jan 25, 2016

Breast Tumors, Breast Cancer, Metastatic Trial in Worldwide (Sagopilone (BAY86-5302, ZK 219477))

Completed
  • Breast Neoplasms
  • Breast Cancer, Metastatic
  • Sagopilone (BAY86-5302, ZK 219477)
  • Wien, Austria
  • +20 more
Nov 27, 2014

Prostate Cancer, Ovarian Cancer Trial in Worldwide (Sagopilone 16 mg/m^2 i.v., Acetyl-L-Carnitine (ALC) 1000 mg tid, HRPC only:

Completed
  • Prostate Cancer
  • Ovarian Cancer
  • Sagopilone 16 mg/m^2 i.v., Acetyl-L-Carnitine (ALC) 1000 mg tid, HRPC only: Prednisone or Prednisolone 5 mg bid
  • Sagopilone 16 mg/m^2 i.v. and placebo 1000 mg tid, HRPC only: Prednisone or Prednisolone 5 mg bid
  • Bruxelles - Brussel, Belgium
  • +21 more
Oct 27, 2014